Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
Clinical trial NCT01059422 · COMPLETED
Trial details
- NCT number
- NCT01059422
- Sponsor
- Central Institute of Epidemiology, Moscow, Russia
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.